Silke Gillessen
Active 1992–2025
- 163
- Papers
- 30,662
- Citations
- 79
- h-index
- 155
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine71.2%
- Biochemistry, Genetics and Molecular Biology13.3%
- Immunology and Microbiology8.8%
- Chemistry2%
- Neuroscience1%
- Computer Science0.8%
- Other2.9%
Topics
- Prostate Cancer Treatment and Research14.7%
- Prostate Cancer Diagnosis and Treatment11.3%
- Radiopharmaceutical Chemistry and Applications3.4%
- Immunotherapy and Immune Responses2.9%
- Cancer Immunotherapy and Biomarkers2.6%
- Cancer, Lipids, and Metabolism2.5%
- Other62.6%
Coauthors
- Karim Fizazi38
- Maria De Santis27
- Gerhardt Attard25
- Nicholas D. James24
- Bertrand Tombal23
- Christopher J. Sweeney21
- Malcolm D. Mason21
- Noel W. Clarke21
- Richard Cathomas17
- Johann S. de Bono16
- Nicolas Mottet16
- Olivier Rouvière16
- Erik Briers15
- Gedske Daugaard15
- Ivo G. Schoots15
- Robert J. Jones15
- Stefano Fanti15
- Alberto Briganti14
- Alison Birtle14
- Axel Heidenreich14
- Daniela E. Oprea‐Lager14
- Derya Tilki14
- Roderick C.N. van den Bergh14
- Thomas Wiegel14
All papers
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Authors: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Philip Cornford - European Urology 2020 cited by 2,814
- Prostate cancer
Authors: Richard J. Rebello, Christoph Oing, Karen E. Knudsen, Stacy Loeb, David C. Johnson, Robert E. Reiter, Silke Gillessen, Theodorus van der Kwast, Robert G. Bristow - Nature Reviews Disease Primers 2021 cited by 1,109
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
Authors: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann Henry, Michael Lardas, Geert J.L.H. van Leenders, Matthew Liew, Estefanía Linares, Jan Oldenburg, Inge M. van Oort, Daniela E. Oprea‐Lager, Guillaume Ploussard, Matthew J. Roberts, Olivier Rouvière, Ivo G. Schoots, Natasha Schouten, Emma Jane Smith, Johan Stranne, Thomas Wiegel, Peter-Paul Willemse, Derya Tilki - European Urology 2024 cited by 1,087
- The Lancet Commission on prostate cancer: planning for the surge in cases
Authors: Nicholas D. James, Ian F. Tannock, James N’Dow, Felix Y. Feng, Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, Bissan Al‐Lazikani, Gerhardt Attard, Freddie Bray, Éva Compérat, Rosalind A. Eeles, Omolara Fatiregun, Emily Grist, Susan Halabi, Áine Haran, Daniel Herchenhorn, Michael S. Hofman, Mohamed Jalloh, Stacy Loeb, Archie Macnair, Brandon A. Mahal, Larissa Mendes, Masood Moghul, Caroline M. Moore, Alicia K. Morgans, Michael J. Morris, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 cited by 643
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors: Chris Parker, Elena Castro, Karim Fizazi, Axel Heidenreich, Piet Ost, Giuseppe Procopio, Bertrand Tombal, Silke Gillessen - Annals of Oncology 2020 cited by 953
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Authors: Nicholas D. James, Johann S. de Bono, Melissa Spears, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, A.W.S. Ritchie, Claire Amos, Clare Gilson, Robert J. Jones, David Matheson, Robin Millman, Gerhardt Attard, Simon Chowdhury, William Cross, Silke Gillessen, Christopher Parker, John M. Russell, Dominik Berthold, Chris Brawley, F. Adab, San Aung, Alison Birtle, Jo Bowen, Susannah Brock, Prabir Chakraborti, Catherine Ferguson, Joanna Gale, Emma Gray, Mohan Hingorani, Peter Hoskin, J.F. Lester, Zafar Malik, Fiona McKinna, Neil McPhail, Julian Money‐Kyrle, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh Parmar, Matthew R. Sydes - New England Journal of Medicine 2017 cited by 1,772
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors: Tom Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2021 cited by 525
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors: Bernard Escudier, Camillo Porta, Manuela Schmidinger, Nathalie Rioux‐Leclercq, Axel Bex, Vincent Khoo, Viktor Grünwald, Silke Gillessen, Alan Horwich - Annals of Oncology 2019 cited by 1,159
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Authors: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Nicolas Mottet - European Urology 2020 cited by 1,126
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Authors: Christopher Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Alex Hoyle, Adnan Ali, A.W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, John M. Russell, George N. Thalmann, Claire Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa Gannon, Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes - The Lancet 2018 cited by 1,262
- Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Authors: Nicolò Pernigoni, Elena Zagato, Arianna Calcinotto, Martina Troiani, Ricardo Pereira Mestre, Bianca Calì, Giuseppe Attanasio, Jacopo Troisi, Mirko Minini, Simone Mosole, Ajinkya Revandkar, Emiliano Pasquini, Angela Rita Elia, Daniela Bossi, Andrea Rinaldi, Pasquale Rescigno, Penny Flohr, Joanne Hunt, Antje Neeb, Lorenzo Buroni, Christina Guo, Jonathan Welti, Matteo Ferrari, Matteo Grioni, Josée Gauthier, Raad Z. Gharaibeh, Anna Palmisano, Gladys Martinetti Lucchini, Eugenia D’Antonio, Sara Merler, Marco Bolis, Fabio Grassi, Antonio Esposito, Matteo Bellone, Alberto Briganti, María Rescigno, Jean‐Philippe Theurillat, Christian Jobin, Silke Gillessen, Johann S. de Bono, Andrea Alimonti - Science 2021 cited by 322
- Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Authors: Thomas Powles, Kobe Yuen, Silke Gillessen, Edward E. Kadel, Dana E. Rathkopf, Nobuaki Matsubara, Charles G. Drake, Karim Fizazi, Josep M. Piulats, Piotr J. Wysocki, Gary L. Buchschacher, B. Yа. Alekseev, Begoña Mellado, Bogusława Karaszewska, Jennifer Doss, Grozdana Rasuo, Asim Datye, Sanjeev Mariathasan, Patrick Williams, Christopher J. Sweeney - Nature Medicine 2022 cited by 242
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, Tobias Gross, Lisa Moris, Erik Briers, Marcus Cumberbatch, Maria De Santis, Derya Tilki, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Olivier Rouvière, Jakub Pecanka, Malcolm D. Mason, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Yuhong Yuan, Thomas Lam, Philip Cornford, Nicolas Mottet - European Urology 2018 cited by 517
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Authors: Derya Tilki, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann Henry, Michael Lardas, Geert J.L.H. van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M. van Oort, Daniela E. Oprea‐Lager, Guillaume Ploussard, Matthew J. Roberts, Olivier Rouvière, Ivo G. Schoots, Natasha Schouten, Emma Jane Smith, Johan Stranne, Thomas Wiegel, Peter-Paul Willemse, Philip Cornford - European Urology 2024 cited by 313
- Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157
- Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
Authors: Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, Christopher C Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Claire L Amos, Nafisah Atako, Cheryl Pugh, Michelle Buckner, Simon Chowdhury, Zafar Malik, J Martin Russell, Clare Gilson, Hannah Rush, Jo Bowen, Anna Lydon, Ian Pedley, Joe M O'Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzoueb, Omi Parikh, Angus Robinson, Isabel Syndikus, James Wylie, Anjali Zarkar, George Thalmann, Johann S de Bono, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Warren Grant, Katherine Hyde, Ami Sabharwal, Uschi Hofmann, Robert Dealey and 73 more - The Lancet 2021 cited by 367
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors: T. Powles, Laurence Albigès, Axel Bex, Éva Compérat, Viktor Grünwald, Ravindran Kanesvaran, H. Kitamura, R. McKay, Camillo Porta, G. Procopio, Manuela Schmidinger, Cristina Suárez, Jeremy Yuen‐Chun Teoh, Guillermo de Velasco, Matthew R. Young, Silke Gillessen - Annals of Oncology 2024 cited by 300
- ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma
Authors: Thomas Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2024 cited by 159
- Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Authors: N.W. Clarke, Amin Ali, Fiona C. Ingleby, Alex Hoyle, Claire Amos, Gerhardt Attard, Chris Brawley, J. Calvert, S. Chowdhury, Audrey Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Silke Gillessen, Robert J. Jones, Ruth E. Langley, Archie Macnair, Zafar Malik, Malcolm D. Mason, David Matheson, R. Millman, Chris Parker, A.W.S. Ritchie, Hannah Rush, John M. Russell, Janet E. Brown, S. Beesley, Alison Birtle, Lisa Capaldi, Joanna Gale, Stephanie Gibbs, Anna Lydon, Ashok Nikapota, Aurelius Omlin, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Sarah Rudman, Narayanan Srihari, Matthew Simms, Jacob Tanguay, Shaun Tolan, John Wagstaff, Jan Wallace, J. Wylie, Anjali Zarkar, Matthew R. Sydes, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2019 cited by 398
- Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
Authors: Marco Bolis, Daniela Bossi, Arianna Vallerga, Valentina Ceserani, Manuela Cavalli, Daniela Impellizzieri, Laura Di Rito, Eugenio Zoni, Simone Mosole, Angela Rita Elia, Andrea Rinaldi, Ricardo Pereira Mestre, Eugenia D’Antonio, Matteo Ferrari, Flavio Stoffel, Fernando Jermini, Silke Gillessen, Lukas Bubendorf, Peter Schraml, Arianna Calcinotto, Eva Corey, Holger Moch, Martin Spahn, George N. Thalmann, Marianna Kruithof‐de Julio, Mark A. Rubin, Jean‐Philippe Theurillat - Nature Communications 2021 cited by 110
- Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Authors: Gerhardt Attard, Laura Murphy, Noel W. Clarke, Ashwin Sachdeva, Craig Jones, Alex Hoyle, William Cross, Robert J. Jones, Christopher Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Clare Gilson, Hannah Rush, Hoda Abdel-Aty, Claire Amos, Claire Murphy, Simon Chowdhury, Zafar Malik, John M. Russell, Nazia Parkar, Cheryl Pugh, Carlos Díaz-Montaña, Carmel Pezaro, Warren Grant, Helen Saxby, Ian Pedley, Joe M. O’Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzouebi, Omi Parikh, Angus Robinson, Amir Montazeri, James Wylie, Anjali Zarkar, Richard Cathomas, Michael D. Brown, Yatin Jain, David P. Dearnaley, Malcolm D. Mason, Duncan C. Gilbert, Ruth E. Langley, Robin Millman, David Matheson, Matthew R. Sydes, Louise Brown, Mahesh Parmar, Nicholas D. James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, D. Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, M. Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan B. McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry M. Taylor, John D. Graham and 80 more - The Lancet Oncology 2023 cited by 102
- Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118
- Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
Authors: Karim Fizazi, Silke Gillessen - Annals of Oncology 2023 cited by 117
- Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations
Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Erik Briers, Philip Cornford, Marcus Cumberbatch, Derya Tilki, Maria De Santis, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Olivier Rouvière, Thomas Lam, Nicolas Mottet - European Urology Focus 2019 cited by 242
